Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 392

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 392
---
 do not alter the obligations of Meyer under the agreement. Under our agreement with Meyer, genomic diagnostic services offered through the Heritas Diagnostics division encompass various applications, including reproductive health, rare diseases, hereditary cancer, and human microbiome analysis. These services include sample quality control, sequencing performed on Illumina platforms, bioinformatic data analysis, interpretation of genetic variants related to health conditions, and the generation of genomic diagnostic reports. The percentage of revenue attributable to the distribution agreement with Meyer is approximately 1.2% of our total revenues for the period reported in this prospectus. On March 11, 2024, we entered into a services agreement with Meyer in Paraguay, as amended on November1, 2024, pursuant to which we process and perform the sequencing of samples provided by Meyer and we deliver the results to Meyer. The service includes receiving and evaluating the quality of genetic material (DNA, RNA) from samples sent by the client, analyzing samples using Illumina’s next generation sequencing instruments, generating and analyzing bioinformatics data, assessing genetic variants related to health conditions, and providing diagnostic reports. Under the services agreement, invoicing occurs monthly and includes detailed descriptions of each service. 197 The term of the services agreement is one year, with the option for either party to terminate early with 30 days’ written notice. If no notice is given, a one -monthservice fee for exit costs will be billed when the agreement is terminated. The parties are independent, and no partnership, joint venture, or representation relationship is created between them. Genetics Institute of America In the past, we entered into a memorandum of understanding with the Genetics Institute of America which was not renewed. However, once the Mexican Wet -Labis built, we expect to pursue new commercial opportunities with them to develop our expansion in Latin America. Environmental Matters We are committed to upholding compliance with all environmental laws applicable to our operations and products, and we are aware of the need to take steps to address our environmental footprint. We take our responsibility for environmental stewardship seriously and believe that we must do our part in addressing global climate change challenges. Additionally, our operations require the use of laboratory equipment, laboratory and hazardous materials as well as biological samples such as saliva, stool, blood and tissue, that subject it to a variety of federal, state and local environmental and safety laws and regulations, which could lead to liability for damages and fines as a result of our, or others’, business operations should contamination of the environment or individual exposure to hazardous substances occur. We recognize